PUMA BIOTECHNOLOGY, INC.: capex
| Value | {"amount": 95000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-09-30 |
| Status | current |
| Entity | PUMA BIOTECHNOLOGY, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:37:34.551981+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/142cf063-52ac-4eb3-9305-006a677d5581
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001437749-23-030028Retrieved: 2026-08-19T13:37:34.551981+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001401667/capex/2023-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/142cf063-52ac-4eb3-9305-006a677d5581
History
- no predecessors — first report